Wiley Online Library - 25 Feb 2024
Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study - Morise - 2024 - Cancer Science ...
Sports Video Group - 19 Sep 2024
SVG New Sponsor Spotlight: As HDR10+ Adoption Grows, Bill Mandel and Makoto Morise Detail How It Benefits Live Sports Content ...
ASCO Journals - 30 Dec 2021
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE | Journal of Clinical Oncology ...
Wiley Online Library - 07 Sep 2020
Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study ...
ASCO Journals - 18 Nov 2021
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE | Journal of Clinical Oncology ...
Nature.com - 03 Feb 2023
Visibility of early gastric cancers by texture and color enhancement imaging using a high-definition ultrathin transnasal endoscope ...